Ghias Babar 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Jul 28, 2025
Insider Transaction Report
Form 4
Ghias Babar
CFO & Head of Corp Development
Transactions
- Award
Common Stock
2025-07-24+147,000→ 147,000 total - Award
Emp. Stock Option (Right to Buy)
2025-07-24+305,000→ 305,000 totalExercise: $8.55From: 2026-07-24Exp: 2035-07-24→ Common Stock (305,000 underlying)
Footnotes (2)
- [F1]Inducement grant of restricted stock units pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan, as amended and restated (the "Stock Incentive Plan"), which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant.
- [F2]Inducement grant of employee stock options pursuant to the Stock Incentive Plan, which will become exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.